Sutezolid
CAS: 168828-58-8
Ref. 3D-TGA82858
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Sutezolid
Sinónimos:
- (S)-N-((3-(3-Fluoro-4-thiomorpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
- Acetamide, N-[[3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-
- N-({(5S)-3-[3-fluoro-4-(thiomorpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
- N-[[(5S)-3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide
- Pnu 100480
- U 100480
- acetamide, N-[[(5S)-3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
Descripción:
Sutezolid is a novel, orally bioavailable and broad-spectrum antibiotic that inhibits bacterial growth by inhibiting fatty acid synthesis. Its mechanism of action is similar to other antibiotics in the class, including linezolid and ethylene diamine. Sutezolid has been shown to be effective against tuberculosis in CD-1 mice. It binds to the 16S ribosomal RNA of Mycobacterium tuberculosis and inhibits the production of essential fatty acids required for bacterial growth. This drug also has a strong inhibitory effect on the synthesis of mycolic acids, which are key components of mycobacterial cell walls.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
353.41 g/mol
Fórmula:
C16H20FN3O3S
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
